Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Tomas Ganz
University of California Los Angeles, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Intrinsic LifeSciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Co-investigator has equity and investment interest. IP will be used a research tool in project.
Iron physiology and pathology in pregnancy
PROJECT NARRATIVE Adequate iron supply during pregnancy is essential for fetal development and maternal health. How iron transfer from the mother to the fetus is regulated in healthy or complicated pregnancies is poorly understood. We propose to define endocrine regulation of iron homeostasis in pregnancy, determine how maternal iron status controls placental iron transport, and elucidate how maternal iron excess potentiates adverse effects of inflammation during pregnancy.
Filed on June 26, 2019.
Tell us what you know about Tomas Ganz's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Tomas Ganz”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | Value cannot be readily determined |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Intrinsic LifeSciences, LLC | Value cannot be readily determined |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | Value cannot be readily determined |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | $0 - $4,999 |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | $0 - $4,999 |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Intrinsic LifeSciences, LLC | $40,000 - $59,999 |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | $0 - $4,999 |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Intrinsic Life Sciences | $5,000 - $9,999 |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | $10,000 - $19,999 |
| Tomas Ganz | University of California Los Angeles | Conflict of Interest | Silarus Therpeutics, Inc | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.